ASTHMA MANAGEMENT

Rating : Rate It:
 
There is no comments now for this Slide.
Post a comment
    Post Comment on Twitter
Comments:  
2 Favorites
Sanmay8k7,   favourited this   6 Days ago.
bolaadefuye,   favourited this   1 Years ago.
First Prev [1] Next Last



  Notes
 
 
Slide 1 : ASTHMAMANAGEMENT
Slide 2 : Magnitude of the Problem 15- 20 million asthmatics in India. A recent study conducted in Delhi established asthma prevalence to be 12% in schoolchildren. Significant cause of school/work absence. Health care expenditures very high. Morbidity and mortality are on the rise. JAPI 2002; Vol 50: 462.
Slide 3 : The Treatment Gap in Asthma Patients are not detected Do not seek medical attention No access to health service Missed diagnosis (bronchitis, LRTI)
Slide 4 : Current Understanding of Asthma A chronic inflammatory disorder of the airway Infiltration of mast cells, eosinophils and lymphocytes Airway hyperresponsiveness Recurrent episodes of wheezing, coughing and shortness of breath Widespread, variable and often reversible airflow limitation
Slide 5 : The Underlying Mechanism INFLAMMATION Risk Factors (for development of asthma) AirwayHyperresponsiveness Airflow Limitation Symptoms- (shortness of breath, cough, wheeze) Risk Factors(for exacerbations)
Slide 6 : Asthma: Pathological changes
Slide 7 : Risk Factors that Lead to Asthma Development Predisposing Factors Atopy Causal Factors Indoor Allergens Domestic mites Animal Allergens Cockroach Allergens Fungi Outdoor Allergens Pollens Fungi Occupational Sensitizers Contributing Factors Respiratory infections Small size at birth Diet Air pollution Outdoor pollutants Indoor pollutants Smoking Passive Smoking Active Smoking
Slide 8 : DIAGNOSIS OF ASTHMA History and patterns of symptoms Physical examination Measurements of lung function
Slide 9 : PATIENT HISTORY Has the patient had an attack or recurrent episodes of wheezing? Does the patient have a troublesome cough, worse particularly at night, or on awakening? Does the patient cough after physical activity (eg. Playing)? Does the patient have breathing problems during a particular season (or change of season)?
Slide 10 : Do the patient’s colds ‘go to the chest’ or take more than 10 days to resolve? Does the patient use any medication (e.g. bronchodilator) when symptoms occur? Is there a response? If the patient answers “YES” to any of the above questions, suspect asthma.
Slide 11 : Physical Examination Wheeze - Usually heard without a stethoscope Dyspnoea - Rhonchi heard with a stethoscope Use of accessory muscles Remember - Absence of symptoms at the time of examination does not exclude the diagnosis of asthma
Slide 12 : Diagnostic testing Diagnosis of asthma can be confirmed by demonstrating the presence of reversible airway obstruction using Peak flow meter.
Slide 13 : Classification of Asthma Severity STEP 4 Severe Persistent STEP 3 Moderate Persistent STEP 2 Mild Persistent STEP 1 Intermittent The presence of one of the features of severity is sufficient to place a patient in that category. Global Initiative for Asthma (GINA) WHO/NHLBI, 2002 Symptoms NighttimeSymptoms PEF CLASSIFY SEVERITYClinical Features Before Treatment Continuous Limited physical activity Daily Use b2-agonist dailyAttacks affect activity >1 time a week but <1 time a day < 1 time a week Asymptomatic and normal PEF between attacks Frequent >1 time week >2 times a month <2 times a month <60% predicted Variability >30% >60%-<80% predicted Variability >30% >80% predicted Variability 20-30% >80% predicted Variability <20%
Slide 14 : Goals to Be Achieved in Asthma Control Achieve and maintain control of symptoms Prevent asthma episodes or attacks Minimal use of reliever medication No emergency visits to doctors or hospitals Maintain normal activity levels, including exercise Maintain pulmonary function as close to normal as possible Minimal (or no) adverse effects from medicine
Slide 15 : Tool Kit for Achieving Management Goals Relievers Preventers Peak Flow meter Patient education
Slide 16 : What Are Relievers? Rescue medications Quick relief of symptoms Used during acute attacks Action lasts 4-6 hrs
Slide 17 : RELIEVERS Short acting ?2 agonists Salbutamol Levosalbutamol Anti-cholinergics Ipratropium bromide Xanthines Theophylline Adrenaline injections
Slide 18 : What are Preventers? Prevent future attacks Long term control of asthma Prevent airway remodelling
Slide 19 : PREVENTERS Corticosteroids Anti-leukotrienes Prednisolone, Betamethasone Montelukast, Zafirlukast Beclomethasone, Budesonide Fluticasone Xanthines Theophylline SR Long acting ?2 agonists Mast cell stabilisers Bambuterol, Salmeterol Sodium cromoglycate Formoterol COMBINATIONS Salmeterol/Fluticasone Formoterol/Budesonide Salbutamol/Beclomethasone
Slide 20 : Reliever Reliever (also known as rescue medication) Bronchodilator (beta2 agonist) Quickly relieves symptoms (within 2-3 minutes) Not for regular use
Slide 21 : Rescue Medication SALBUTAMOL INHALER 100 mcg: 1 or 2 puffs as necessary LEVOSALBUTAMOL INHALER 50 mcg : 1 or 2 puffs as necessary
Slide 22 : Anti-inflammatory Takes time to act (1-3 hours) Long-term effect (12-24 hours) Only for regular use (whether well or not well) Preventer
Slide 23 : ICS + LABA Which LABA ? Formoterol: Immediate relief (as fast as salbutamol) 12 hours effect Can be combined with budesonide
Slide 24 : Ideal combination Formoterol ( fast relief and sustained relief ) + Budesonide ( twice or even once daily use ) Dose: 1- 4 puffs ( OD/BD ) Another combination Salmeterol + Fluticasone
Slide 25 :
Slide 26 : All Asthma Drugs Should Ideally Be Taken Through The Inhaled Route.
Slide 27 : Why inhalation therapy? Oral Slow onset of action Large dosage used Greater side effects Not useful in acute symptoms Inhaled route Rapid onset of action Less amount of drug used Better tolerated Treatment of choice in acute symptoms
Slide 28 : Aerosol delivery systems currently available Metered dose inhalers Dry powder inhalers (Rotahaler) Spacers / Holding chambers
Slide 29 : Spacer Dry PowderInhaler Metered Dose inhaler Inhalation devices you can use
Slide 30 : Advantages of Spacer No co-ordination required No cold - freon effect Reduced oropharyngeal deposition Increased drug deposition in the lungs
Slide 31 : The Zerostat advantage Non - static spacer made up of polyamide material Increased respirable fraction ® Increased deposition of drug in the airways Increased aerosol half - life ® Plenty of time for the patient to inhale after actuation of the drug No valve ® No dead space ® Less wastage of the drug Small, portable, easy to carry ® Child friendly
Slide 32 : Rotahaler - The dry powder advantage Overcomes hand-lung coordination problems that are encountered with MDIs. Can be easily used by children, elderly and arthritic patients. Can take multiple inhalations if the entire drug has not been inhaled in one inhalation.
Slide 33 : Age-wise selection of inhaler devices < 3 years – MDI + Spacer + Mask or nebulisers 3 – 5 years – MDI + Spacer + Mask or Rotahaler 5 – 8 years – Rotahaler or MDI + Spacer > 8 years – Rotahaler or MDI + Spacer
Slide 34 : Patient Education in the Clinic Explain nature of the disease (i.e. inflammation) Explain action of prescribed drugs Stress need for regular, long-term therapy Allay fears and concerns Peak flow reading Treatment diary / booklet
Slide 35 : Key Messages Asthma is a common disorder It can happen to anybody It is not caused by supernatural forces Asthma is not contagious It produces recurrent attacks of cough with or without wheeze Between attacks people with asthma lead normal lives as anyone else In most cases there is some history of allergy in the family.
Slide 36 : Key Messages Asthma can be effectively controlled, although it cannot be cured. Effective asthma management programs include education, objective measures of lung function, environmental control, and pharmacologic therapy. A stepwise approach to pharmacologic therapy is recommended. The aim is to accomplish the goals of therapy with the least possible medication.

 


Related  Most Viewed

More By User

Flag as inappropriate

Free Medical Powerpoint Templates
Add as Friend SlidesOnline     3 Years ago.

Category: Allergy
Tags:
Embed:
6709 Views, 3 favourite
Effective asthma management programs include education, objective measures of lung function, enviro    more





Featured | Myworld | Browse | Patients | Popular | Latest | Tags | Conferences | Contact | Feedback | About Us | FAQ | RSS

Powerpoint Templates

Animated Powerpoint Templates | Business Powerpoint Templates | Education PPT |Mac PPT | Medical Powerpoint Templates |Powerpoint Maps | Technology PPT

copyright © www.SlideWorld.org